{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:54:59Z","timestamp":1781517299950,"version":"3.54.1"},"reference-count":15,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Influenza viruses remain a formidable challenge to global public health, causing annual epidemics and intermittent pandemics, and resulting in over 3 million severe infections with 290,000\u2013650,000 deaths annually [...]<\/jats:p>","DOI":"10.3390\/vaccines14060527","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:57:58Z","timestamp":1781513878000},"page":"527","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunity to Influenza Viruses and Vaccines: From Broader Immunity to Chrono-Optimization and Safety"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1139-3607","authenticated-orcid":false,"given":"Rongbao","family":"Gao","sequence":"first","affiliation":[{"name":"NHC Key Laboratory of Biosafety, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100 Changbai RD, Changping District, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: A modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Roberts, N.J., and Krilov, L.R. (2022). The Continued Threat of Influenza A Viruses. Viruses, 14.","DOI":"10.3390\/v14050883"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bsheal.2024.10.001","article-title":"A comparative analysis of influenza and COVID-19: Environmental-ecological impacts, socioeconomic implications, and future challenges","volume":"6","author":"Guo","year":"2024","journal-title":"Biosaf. Health"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Nishiyama, A., Nogimori, T., Masuta, Y., Matsuura, T., Kase, T., Kondo, K., Ohfuji, S., Nakagama, Y., Kaku, N., and Nakagama, S. (2025). Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination. Vaccines, 13.","DOI":"10.3390\/vaccines13020140"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Uno, N., Thomas, M.H., Caetano, C., and Ross, T.M. (2026). Elicitation of Protective Immune Responses Against Influenza Virus Following Intranasal Delivery of Fluzone or Flublok Vaccines. Vaccines, 14.","DOI":"10.3390\/vaccines14010103"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Hjelholt, A.J., Bergh, C., Bhatt, D.L., Frobert, O., and Kjolby, M.F. (2023). Pleiotropic Effects of Influenza Vaccination. Vaccines, 11.","DOI":"10.3390\/vaccines11091419"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Akhtar, Z., Moa, A.M., Tan, T.C., Frobert, O., Menzies, R., and MacIntyre, C.R. (2025). Prevention of Cardiovascular Diseases with Standard-Dose Quadrivalent Influenza Vaccine in People Aged \u226550 Years in Australia During the 2017 A\/H3N2 Epidemic. Vaccines, 13.","DOI":"10.3390\/vaccines13040407"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Artiaga, B.L., Madden, D., Kwon, T., McDowell, C., Keating, C., Balaraman, V., de Carvahlo Madrid, D.M., Touchard, L., Henningson, J., and Meade, P. (2024). Adjuvant Use of the Invariant-Natural-Killer-T-Cell Agonist \u03b1-Galactosylceramide Leads to Vaccine-Associated Enhanced Respiratory Disease in Influenza-Vaccinated Pigs. Vaccines, 12.","DOI":"10.3390\/vaccines12091068"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yoon, Y., Cho, H.K., Kim, K.H., Park, S.E., Kim, Y.J., Lee, J., Kim, H.M., Kim, N.H., Jo, D.S., and Cho, E.Y. (2026). Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6\u201335 Months: Results from a Multinational Phase 3 Randomised Controlled Trial. Vaccines, 14.","DOI":"10.3390\/vaccines14040341"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/22221751.2019.1605845","article-title":"Continuing evolution of highly pathogenic H5N1 viruses in Bangladeshi live poultry markets","volume":"8","author":"Barman","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Nguyen, B.L., Isoda, N., Hew, Y.L., Huynh, L.T., Le, K.T., Shimazu, Y., Kobayashi, D., Nguyen, D.H., Nguyen, T.D., and Chu, D.H. (2026). Efficacy and Limitations of an Improved Vaccine Derived from an Updated Vaccine Strain Against H5 High Pathogenicity Avian Influenza. Vaccines, 14.","DOI":"10.3390\/vaccines14040291"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Medina-Armenteros, Y., Cajado-Carvalho, D., das Neves Oliveira, R., Apetito Akamatsu, M., and Lee Ho, P. (2024). Recent Occurrence, Diversity, and Candidate Vaccine Virus Selection for Pandemic H5N1: Alert Is in the Air. Vaccines, 12.","DOI":"10.3390\/vaccines12091044"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zhu, H., Pu, S., He, P., Luo, J., and Gao, R. (2025). Construction and Research Progress of Animal Models and Mouse Adapted Strains of Seasonal Influenza Virus. Vaccines, 13.","DOI":"10.3390\/vaccines13101077"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wei, Y., Sun, K., Han, X., Sun, Y., Zhang, J., Wang, Y., Yin, Q., Yang, T., Yuan, K., and Li, M. (2025). Application of Humanized MHC Transgenic Mice in the Screening of HLA-Restricted T Cell Epitopes for Influenza Vaccines. Vaccines, 13.","DOI":"10.3390\/vaccines13030331"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Livieratos, A., Zeitzer, J.M., and Tsiodras, S. (2025). A Narrative Review on How Timing Matters: Circadian and Sleep Influences on Influenza Vaccine Induced Immunity. Vaccines, 13.","DOI":"10.3390\/vaccines13080845"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/6\/527\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:36:12Z","timestamp":1781516172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/6\/527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,14]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["vaccines14060527"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14060527","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,14]]}}}